Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: BobbleUnc who wrote (2304)	4/15/1999 11:39:00 PM
From: Duke	Read Replies (1) \| Respond to of 4140

Here are the LTK talks/ASCRS ragingbull.com I've been meaning to post this, but got busy at work. Here are the LTK talks and the conclusions from the ASCRS do in Seattle. I think this will make believers out of the skeptics, shorters and daytraders. Paper 362 Retreatment after previous PRK and Lasik for myopia using the Sunrise holmium LTK system. Frank Goes MD (he's in Belgium-he told me he's going to get a hyperion. Conclusion: Holmium yag retreatment using the non-contact Sunrise holmium LTK system was very effective in retreating hyperopic overcorrections after previous myopic refractive surgery (PRK and Lasik). Better adjustment of treatment parameters should become possible with the second generation of Sunrise system (the Hyperion). Paper 363 Presbyopic LTK treatment Till Anschutz MD Conclusion: A binocular presbyopic correction with LTK is an encouraging procedure with an improvement of near UCVA. Paper 364 Holmium laser thermal keratoplasty to correct hyperopia with the Sunrise corneal shaping system. Guillermo Rocha MD Conclusion: The Ho-Yag Sunrise corneal laser system is a safe and effective laser for the treatment of low hyperopia and astigmatism. It provides a predictable refractive outcome at six months of followup. Paper 365 LTK application after hyperopic Lasik procedure. Klaus Ditzen MD Conclusion: LTK after hyperopic Lasik undercorrections more than +3 diopters shows a good predictability and stability. Paper 366 30 month followup in diode laser thermokeratoplasty for hyperopia and astigmatism correction. Thomas Bende PhD, Matthias Derse MD Conclusion:The pilot study results show stable refractive changes after astigmatism and hyperopia LTK. The obtained corrections are the highest reported so far. Paper 367-non LTK paper Paper 368 Sunrise LTK for hyperopia Douglas Koch MD Conclusion:Efficacy and safety data from the US FDA study met or exceeded all FDA target values. Paper 369 Factors affecting outcome of LTK, determined by statistical modeling Sandra Belmont, MD Conclusion: A number of pre-treatment factors affect outcome (i.e., age, race, gender, etc.) Paper 370 Orbscan use in LTK and ICL evaluation Dr. David Brown Conclusion: The versatility of the Orbscan unit can be demonstrated in LTK. Paper 371 Cell loss, glare and contrast studies with Sunrise LTK Howard Fine MD Conclusion: Results of the FDA data for LTK indicate excellent safety for the procedure. Paper 372 Expanding the range of LTK to plus four diopters. Alan Aker MD, Donald Sanders MD, David Brown MD Conclusion: A new treatment pattern appears to extend the effective range of LTK for hyperopia to close to 4D. Paper 373 Quality of vision of LTK using the Sunrise holmium laser Brian S. Boxer Wachler MD Conclusion: holmium yag preserves contrast sensitivity and appears to be a safe procedure. Paper 374 3 years-LTK Till Anschutz MD Conclusion: Results support the safety and efficacy of LTK in the treatment of hyperopia of 2.5 D or less. Paper 375 LTK to treat overcorrected patients following myopic photorefractive keratectomy. Emanuel S. Rosen MD (an English guy, he owns an LTK) Conclusion: Non contact LTK to treat secondary hyperopia showed good results. Paper 376 LTK-an alternative retreatment procedure. Till Anschutz MD LTK is a safe, effective and stable alternative restreatment procedure after overcorrected myopic PRK.